Retrieve available abstracts of 9 articles: HTML format
Single Articles
April 2025
DE MATTIA G, Mazzantini M Reply to the comment on: The great challenge: bone fragility and environment.
Clin Exp Rheumatol. 2025 Apr 18. doi: 10.55563. PubMed
WEISZ GM Comment on: The great challenge: bone fragility and environment.
Clin Exp Rheumatol. 2025 Apr 17. doi: 10.55563. PubMed
March 2025
AL-MAYOUF SM, Alenzi F, Khamaj Y, Aljazaeri S, et al Effectiveness and safety of bisphosphonates in inflammatory bone disorders: a
systematic review.
Clin Exp Rheumatol. 2025 Mar 20. doi: 10.55563. PubMedAbstract available
August 2024
BEAUGER M, Lambert C, Pickering ME, Tournadre A, et al Evolution of bone mineral density after 5 years of TNF-alpha inhibitors in axial
spondyloarthritis.
Clin Exp Rheumatol. 2024 Aug 11. doi: 10.55563. PubMed
July 2024
MAZZANTINI M, De Mattia G The great challenge: bone fragility and environment.
Clin Exp Rheumatol. 2024 Jul 15. doi: 10.55563. PubMedAbstract available
DE MATTIA G, Maffi M, Mazzantini M Anabolic treatment for osteoporosis and fragility fracture risk: one year in
review 2024.
Clin Exp Rheumatol. 2024;42:1311-1316. PubMedAbstract available
January 2024
CHEN CH, Liao HT, Chen HA, Yen YN, et al Denosumab use reduces risk of rheumatoid arthritis in patients with osteoporosis.
Clin Exp Rheumatol. 2024 Jan 5. doi: 10.55563. PubMedAbstract available
December 2023
ADAMI G, Fassio A, Rossini M, Montanari F, et al Long-term effectiveness and predictors of bisphosphonate treatment in type I
complex regional pain syndrome.
Clin Exp Rheumatol. 2023 Dec 4. doi: 10.55563. PubMedAbstract available
May 2023
MAFFI M, De Mattia G, Mazzantini M Osteoporosis and gut microbiota, radiofrequency echographic multispectrometry and
machine learning: one year in review 2023.
Clin Exp Rheumatol. 2023 May 30. doi: 10.55563. PubMedAbstract available